Machine Learning Models Predicting Hospital Admissions During Chemotherapy Utilising Longitudinal Symptom Severity Reports and Patient-Reported Outcome Measures

  • 0UKRI Centre for Doctoral Training in Artificial Intelligence for Medical Diagnosis and Care, University of Leeds, Leeds, UK.

Summary

This summary is machine-generated.

Machine learning models using patient-reported symptom data can predict chemotherapy-related hospital admissions. Incorporating patient-reported outcome measures (PROMs) enhanced model accuracy for better patient care.

Area Of Science

  • Oncology
  • Health Informatics
  • Machine Learning in Medicine

Background

  • Chemotherapy toxicity frequently causes acute hospital admissions, straining healthcare resources and affecting patient quality of life.
  • Existing predictive models for emergency admissions often overlook crucial patient-reported data.

Purpose Of The Study

  • To develop and evaluate machine learning (ML) models for predicting hospital admissions risk during chemotherapy using longitudinal symptom data.
  • To assess the impact of patient-reported outcome measures (PROMs) on the performance of these ML models.
  • To compare the predictive accuracy of models with and without PROMs.

Main Methods

  • Longitudinally collected patient symptom severity reports were utilized.
  • Four machine learning models, including Random Forest and Extreme Gradient Boosting, were trained and tested.
  • Model performance was evaluated for predicting overall hospital admissions and short-term (14-day) admissions risk.
  • A comparative analysis was conducted between models developed with and without PROMs.

Main Results

  • Random Forest and Extreme Gradient Boosting models demonstrated excellent predictive performance for hospital admissions (balanced accuracy, recall, specificity > 0.9).
  • Short-term (14-day) admissions risk prediction accuracy was found to be poor.
  • The inclusion of PROMs significantly improved the overall performance of the machine learning models.

Conclusions

  • Longitudinal collection and analysis of symptom severity reports and PROMs are crucial for understanding chemotherapy toxicity.
  • These data-driven insights can enhance the prediction of emergency admissions, informing clinical decision-making and patient management.
  • Integrating PROMs into ML models offers a promising approach to proactively identify patients at risk of chemotherapy-related hospitalizations.

Related Concept Videos